An article includes recommendations for patients with cancer from experts around the country, including Tom Beer, M.D.

Story covers new research by Randy Woltjer, M.D., Ph.D., and colleagues suggesting a connection between bile acid production and Parkinson’s disease.

In a story about clinicians increasingly reluctant to recommend tube feeding in cases of advance dementia, Joan Teno, M.D., says short-term placement of a nasogastric tube may be helpful. She says, “Sometimes, watchful waiting could be a very important strategy.”

A photo of Andy Henning, N.P, ringing a bell and cheering for a vehicle full of newly vaccinated people at the mass vaccination site at PDX is featured in a story about the Alabama Department of Health opening eight large-scale, drive-through vaccination clinics.

OHSU offers free weekly coronavirus testing in Astoria.

In an article describing the side effects people are experiencing after their second dose of the Pfizer or Moderna vaccine, Mark Slifka Ph.D., says: "It’s the body’s knee-jerk reaction to an infection or something that looks like it. Let’s spray the area down with antiviral cytokines, which also happen to be inflammatory.”

In an article on American Indians’ growing presence in health professions, OHSU is mentioned as one of three medical schools nationwide to receive INMED (Indians Into Medicine) grants from the Indian Health Service.

Carlos Crespo, Ph.D., says that the J&J vaccine could be available in Oregon within a month: "Oregon is probably in the same situation as other states. We depend, basically 100%, on what the federal government delivers to the states."

OHSU and medical schools around the country are experiencing an uptick in applications during the pandemic, a trend dubbed the 'Fauci effect'; Susan Shugerman, Ed.D., says OHSU is thrilled to see more people want to join the health field because it's important to have a diverse group working with patients.

New research led by Fikadu Tafesse, Ph.D., suggests that while previous exposure to other coronaviruses may enhance a person's immune response to COVID-19 infection, antibodies triggered by the SARS outbreak of 2003 provide only limited protection against the new coronavirus.